Your browser doesn't support javascript.
loading
Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy.
Uskent, Necdet; Ayla, Sule; Molinas Mandel, Nil; Ozkan, Metin; Teomete, Mehmet; Baloglu, Huseyin; Aydincer, Cenk; Yergok, Hale; Dogan, Ender; Berk, Barkin; Yazar, Aziz.
Affiliation
  • Uskent N; Department of Medical Oncology, Anadolu Health Center, Istanbul, Kocaeli, Turkey.
  • Ayla S; Department of Histology and Embryology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Molinas Mandel N; Department of Medical Oncology, School of Medicine, Koc University, Istanbul, Turkey.
  • Ozkan M; Department of Medical Oncology, School of Medicine, Erciyes University, Kayseri, Turkey.
  • Teomete M; Department of Medical Oncology, Altunizade Acibadem Hospital, Istanbul, Turkey.
  • Baloglu H; Department of Pathology, Anadolu Health Science Center, Istanbul, Kocaeli, Turkey.
  • Aydincer C; Department of Medical Oncology, Anadolu Health Center, Istanbul, Kocaeli, Turkey.
  • Yergok H; Department of Medical Oncology, School of Medicine, Koc University, Istanbul, Turkey.
  • Dogan E; Department of Medical Oncology, School of Medicine, Erciyes University, Kayseri, Turkey.
  • Berk B; Department of Pharmaceutical Chemistry, School of Pharmacy, Istanbul Medipol University, Istanbul, Turkey.
  • Yazar A; Department of Internal Diseases, School of Medicine, Acibadem University, Istanbul, Turkey.
J Oncol ; 2020: 1360431, 2020.
Article in En | MEDLINE | ID: mdl-32670370

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Oncol Year: 2020 Document type: Article Affiliation country: Turquía

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Oncol Year: 2020 Document type: Article Affiliation country: Turquía